Keri Skin Care Brand Finds A Home At Novartis

摘要

Swiss pharmaceutical company Novartis says it plans to stabilize and nurture the Keri skin care brand,which the firm is acquiring as part of its purchase of Bristol-Myers Squibb's OTC business."[Keri] fits very well with an OTC portfolio as it is more medicinal and it has a historic hospital heritage," the company noted."Our short and long term goals are to stabilize the product and grow it," the firm added.